A new weight loss drug is gaining attention, boasting fewer side effects compared to alternatives and experiencing skyrocketing demand. While some see potential in its ability to curb appetite, the discussion highlights that behavioral changes are essential for long-term success. The drug's approval for weight loss marks a shift from its original use for diabetes, raising questions about its broader implications in the market.
